首页> 外国专利> Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles

Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles

机译:包含金属离子螯合物和酸性糖和糖胺聚糖的体内制剂,具有改善的位点选择性定位,摄取机制,敏感性和动力学空间分布

摘要

This application concerns novel agents comprising cationic or chemically basic metal chelators in association with hydrophilic carriers of anionic or chemically acidic saccharides, sulfatoids and glycosaminoglycans. In certain embodiments, the agents comprise metals and metal ions. Covalent and non-covalent chemical and physical means are described for stabilizing the binding of the metal chelators to the carriers. Novel non-covalently bound compositions are described which give uniquely high payloads and ratio of metal chelator to carrier, ranging from a low of about 15% metal chelator by weight, to a characteristic range of 70% to 90% metal chelator by weight. Specific embodiments are described comprising deferoxamine, ferrioxamine, iron- basic porphine, iron-triethylenetetraamine, gadolinium DTPA-lysine, gadolinium DOTA-lysine and gadolinium with basic derivatives of porphyrins, porphines, expanded porphyrins, Texaphyrins and sapphyrins as the basic or cationic metal chelators, which are in turn, bound to acidic or anionic carriers, including one or more of acidic or anionic saccharides, and including sulfated sucrose, pentosan polysulfate, dermatan sulfate, essentially purified dermatan sulfate with a sulfur content of up to 9% and with selective oligosaccharide oversulfation, chondroitin sulfate, oversulfated chondroitin sulfate, heparan sulfate, beef heparin, porcine heparin, non-anticoagulant heparins, and other native and modified acidic saccharides and glycosaminoglycans.
机译:本申请涉及新颖的试剂,其包含阳离子或化学碱性金属螯合剂以及阴离子或化学酸性糖类,类硫酸酯和糖胺聚糖的亲水性载体。在某些实施方案中,所述试剂包含金属和金属离子。描述了用于稳定金属螯合剂与载体结合的共价和非共价化学和物理手段。描述了新颖的非共价结合的组合物,其赋予独特的高有效负载和金属螯合剂与载体的比例,范围从低至约15重量%的金属螯合剂至70重量%至90重量%的特征范围。描述了特定的实施方案,其包含去铁胺,亚铁胺,铁碱性卟啉,铁三亚乙基四胺,DTPA-赖氨酸,DODOTA-赖氨酸和g,并以卟啉,卟啉,膨胀卟啉,得克萨菲金属和sapphyrins的碱性衍生物作为碱性或阳离子型阳离子交换剂。依次与酸性或阴离子载体结合,所述酸性或阴离子载体包括一种或多种酸性或阴离子糖,并包括硫酸化蔗糖,戊聚糖多硫酸盐,硫酸皮肤素,基本上纯化的硫酸皮肤素,其硫含量最高为9%,并且具有选择性寡糖,硫酸软骨素,硫酸软骨素,硫酸乙酰肝素,牛肉肝素,猪肝素,非抗凝肝素以及其他天然和修饰的酸性糖和糖胺聚糖。

著录项

  • 公开/公告号US5707604A

    专利类型

  • 公开/公告日1998-01-13

    原文格式PDF

  • 申请/专利权人 ACCESS PHARMACEUTICALS INC.;

    申请/专利号US19950472634

  • 发明设计人 DAVID F. RANNEY;

    申请日1995-06-07

  • 分类号A61B5/055;

  • 国家 US

  • 入库时间 2022-08-22 02:40:22

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号